0001104659-23-105394.txt : 20230929 0001104659-23-105394.hdr.sgml : 20230929 20230929170100 ACCESSION NUMBER: 0001104659-23-105394 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230928 FILED AS OF DATE: 20230929 DATE AS OF CHANGE: 20230929 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoberman Kenneth CENTRAL INDEX KEY: 0001573722 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 231296475 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 tm2327273-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-09-28 0 0001001316 TG THERAPEUTICS, INC. TGTX 0001573722 Hoberman Kenneth 3020 CARRINGTON MILL BLVD, SUITE 475 MORRISVILLE NC 27560 1 0 0 0 0 Common Stock 2023-09-28 4 A 0 20000 0 A 242685 D Reflects a grant of restricted shares that will vest on June 14, 2024. Includes shares of restricted Common Stock, which vest over various time periods. /s/ Kenneth Hoberman 2023-09-29